Nektar Therapeutics (NKTR) Selling, General & Administrative (2010 - 2026)
Nektar Therapeutics' Selling, General & Administrative was $12.77 million in Q2 2026, down 25.2% from $17.07 million a year earlier and down 5.0% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Selling, General & Administrative (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Nektar Therapeutics' Selling, General & Administrative was $53.46 million through Jun 30, 2026, down 31.0% year-over-year; for FY2025, it was $68.67 million, down 10.5% from FY2024.
- Selling, General & Administrative has now declined for four consecutive years, with a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $76.75 million in FY2024 (-0.9%), $77.42 million in FY2023 (-16.2%), $92.33 million in FY2022 (-24.8%) and $122.84 million in FY2021 (+17.3%).
- Quarterly Selling, General & Administrative has moved between $11.19 million (Q4 2025) and $32.14 million (Q4 2021) over five years.
- Compared with a year earlier, Selling, General & Administrative has declined for five straight quarters, with an average decline of 15.9% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q1 2025 (growth of 20.8%); the worst was Q1 2026 (a decline of 44.8%).
- Per Business Quant data, NKTR's Selling, General & Administrative in the three quarters before Q2 2026 was $13.44 million (Q1 2026), $11.19 million (Q4 2025) and $16.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Nektar Therapeutics | 1.44 Bn | -328.37 Mn | - | 12.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.77 Mn |
| Mar 31, 2026 | 13.44 Mn |
| Dec 31, 2025 | 11.19 Mn |
| Sep 30, 2025 | 16.07 Mn |
| Jun 30, 2025 | 17.07 Mn |
| Mar 31, 2025 | 24.35 Mn |
| Dec 31, 2024 | 17.14 Mn |
| Sep 30, 2024 | 18.96 Mn |
| Jun 30, 2024 | 20.51 Mn |
| Mar 31, 2024 | 20.15 Mn |
| Dec 31, 2023 | 17.32 Mn |
| Sep 30, 2023 | 21.15 Mn |
| Jun 30, 2023 | 17.87 Mn |
| Mar 31, 2023 | 21.08 Mn |
| Dec 31, 2022 | 21.94 Mn |
| Sep 30, 2022 | 22.53 Mn |
| Jun 30, 2022 | 20.52 Mn |
| Mar 31, 2022 | 27.34 Mn |
| Dec 31, 2021 | 32.14 Mn |
| Sep 30, 2021 | 29.47 Mn |
API Access
Nektar Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();